Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014)
Armata Pharmaceuticals (ARMP) posted Exchange Rate Effect of -$93000.0 for Q3 2014, down 481.25% sequentially from -$16000.0 in Q2 2014, and down 342.86% YoY from $38294.1 in Q3 2013.
Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014) Analysis & Trends
Armata Pharmaceuticals has reported Exchange Rate Effect for 2 years, with the latest figure at -$93000.0 in Q3 2014.
- Quarterly Exchange Rate Effect fell 342.86% year-over-year to -$93000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was -$96000.0 (changed N/A YoY) and the FY2013 annual result came in at $41000.0, changed N/A from the prior year.
- Exchange Rate Effect fell to -$93000.0 in Q3 2014 per ARMP's latest filing, from -$16000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $158000.0 in Q2 2013 and troughed at -$113000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.09 Bn | 131.23 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.66 Bn | 77.66 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.86 Bn | 59.67 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.87 Bn | 36.77 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.45 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Armata Pharmaceuticals | 183.37 Mn | 159.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -93,000.00 |
| Sep 30, 2014 | -93,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Mar 31, 2013 | -113,000.00 |
| Mar 31, 2013 | -113,000.00 |